Cardlytics Gains On SRS Dispute Settlement
(RTTNews) - Cardlytics, Inc. (CDLX) shares are progressing more than 26 percent on Monday morning trade announced that it has entered into a settlement agreement with Shareholder Representative Services LLC, or SRS, and successfully resolved all disputes related to the Bridg merger agreement and the earnout payments.
Further, Cardlytics expects to achieve positive adjusted EBITDA for the full year 2023.
Currently, shares are at $7.25, up 25.65 percent from the previous close of $5.77 on a volume of 3,565,672.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.